Notes
Slide Show
Outline
1
Hyponatremia in Neurosurgerical Patients: Clinical Guidelines Development
2
Evidence Based Medicine
  • EBM term coined by Guyatt in 1991


  • “Conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients”
3
Clinical Guidelines
  • Historically based on expert consensus - GOBSAT
  • Now EBM methodology applied to a population
  • “systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances”
4
Focus on Outcome
  • Assure best chance of achieving acceptable outcome
  • Reduce wide range of variation in tx options
  • Reduce costs of delivery
  • Balance of risks, benefits & costs
5
Multi-disciplinary hyponatremia workgroup
  • Neurosurgery - WAF, SNR, neurosurgical ARNPs
  • CCM - Bihorac
  • Endocrinology - Kennedy
  • Nephrology - Tantravahi, Segal
  • Pharmacy - Leclaire
  • Nursing - multiple
6
Define major questions
  • When should hyponatremia be further evaluated and treated? (what lab values and/or clinical symptoms require intervention)
  • What is the optimal evaluation paradigm, clinical and laboratory, for hyponatremia in the neurosurgical setting?
  • What is the optimal treatment paradigm for hyponatremia in the neurosurgical setting?


7
Collection of Data
  • Literature search for clinical trials, meta-analyses, prospective studies, case control, case reports & reviews
  • English
  • PubMed & Cochrane database
  • Hyponatremia
  • Over 75 articles reviewed
8
Question 1: When should hyponatremia be further evaluated and treated?

  • Literature on prognosis
  • 14 studies
  • 6 retrospective studies - considered invalid for prognostic questions


9
Classification of Evidence on Prognosis

  • Class I: Well-designed clinical trial, population followed from uniform point in disease process, no bias, multivariate analysis
  • Class II: Data on restricted population, prospective, complete follow-up, multivariate analysis
  • Class III: Expert opinion, other prospective studies


10
 
11
When should hyponatremia be further evaluated and treated?
  • Recommendation:


  • Hyponatremia should be further investigated and treated when Na <131mmol/L. (II)
12
Question 2: What is the optimal evaluation paradigm, both clinical and laboratory, for hyponatremia in the neurosurgical setting?

  • Literature on diagnosis
  • 37 studies
  • 17 prospective
  • 14 reviews



13
Classification of Evidence on Diagnostic Tests
  • Class I: Well-designed clinical study, diverse population, “gold standard” test in blinded eval, sensitivity, specificity, pos and neg predictive values
  • Class II: Restricted pop, reference test in blinded eval, sensitivity, specificity, pos and neg predictive values
  • Class III: Expert opinion, studies w/o above criteria
14
 
15
 
16
What is the optimal evaluation paradigm, both clinical and laboratory, for hyponatremia in the neurosurgical setting?
  • Recommendation:
  • Evaluation of hyponatremia should include a combination of physical exam findings, basic lab studies and invasive monitoring when available. (III)
  • Obtaining levels of hormones such as ADH and natriuretic peptides is not supported by the literature. (III)



17
Multi-disciplinary recommendations for UF
  • Literature reviewed
  • Consensus recommendations for the paradigm for evaluation of hyponatremia at UF
18
 
19
 
20
Question 3: What is the optimal treatment paradigm for hyponatremia in the neurosurgical setting?

  • 35 Studies
  • 3 Randomized controlled trials
  • 11 Prospective
  • 7 Retrospective/case reports
  • 15 Reviews



21
Classification of Evidence on Therapeutic Effectiveness

  • Class I: Randomized controlled trial
  • Class II: Comparative study, cohort study, case-control
  • Class III: Case series, comparative study with historical controls, case reports and expert opinion
22
 
23
 
24
What is the optimal treatment paradigm for hyponatremia in the neurosurgical setting?
  • Recommendation:
  • Sodium should not be corrected by more than 10mmol/day. (III)
  • Treatment of hyponatremia should be based on severity of symptoms. (III)
  • CSW should be treated with replacement of Na and IVF. (III)
  • Fludrocortisone may be considered in the treatment of hyponatremia in SAH patients at risk for vasospasm. (I)
  • Hydrocortisone may be used to prevent natriuresis in SAH patients. (II)
  • SIADH may be treated with urea, diuretics, lithium, demeclocycline and/or fluid restriction. (III)
  • Hyponatremia in SAH patients at risk for vasospasm should not be treated with fluid restriction. (II)


25
 
26
 
27
 
28
 
29
Questions?
30
Bibliography
  • 1. Aiyagari V, Deibert E, Diringer MN: Hypernatremia in the neurologic intensive care unit: how high is too high? J Crit Care 21:163-172, 2006
  • 2. Anderson RJ, Chung HM, Kluge R, et al: Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 102:164-168, 1985
  • 3. Arieff AI: Management of hyponatraemia. Bmj 307:305-308, 1993
  • 4. Arieff AI: Osmotic failure: physiology and strategies for treatment. Hosp Pract (Off Ed) 23:173-178, 183-174, 187-179 passim, 1988
  • 5. Arieff AI, Llach F, Massry SG: Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore) 55:121-129, 1976
  • 6. Ashraf N, Locksley R, Arieff AI: Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 70:1163-1168, 1981
  • 7. Atchison JW, Wachendorf J, Haddock D, et al: Hyponatremia-associated cognitive impairment in traumatic brain injury. Brain Inj 7:347-352, 1993
  • 8. Ayus JC, Krothapalli RK, Arieff AI: Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. N Engl J Med 317:1190-1195, 1987
  • 9. Ayus JC, Wheeler JM, Arieff AI: Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med 117:891-897, 1992
  • 10. Bartter FC, Schwartz WB: The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 42:790-806, 1967
  • 11. Baylis PH: The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol 35:1495-1499, 2003
  • 12. Berendes E, Walter M, Cullen P, et al: Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 349:245-249, 1997
  • 13. Berger TM, Kistler W, Berendes E, et al: Hyponatremia in a pediatric stroke patient: syndrome of inappropriate antidiuretic hormone secretion or cerebral salt wasting? Crit Care Med 30:792-795, 2002
  • 14. Betjes MG: Hyponatremia in acute brain disease: the cerebral salt wasting syndrome. Eur J Intern Med 13:9-14, 2002
  • 15. Christensen JH, Rittig S: Familial neurohypophyseal diabetes insipidus--an update. Semin Nephrol 26:209-223, 2006
  • 16. Chung HM, Kluge R, Schrier RW, et al: Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med 83:905-908, 1987
  • 17. Cobb WE, Spare S, Reichlin S: Neurogenic diabetes insipidus: management with dDAVP (1-desamino-8-D arginine vasopressin). Ann Intern Med 88:183-188, 1978
  • 18. Coenraad MJ, Bolk JH, Frolich M, et al: Plasma arginine vasopressin and atrial natriuretic peptide concentration in patients with hyponatremia at diagnosis and following treatment. Eur J Intern Med 18:221-229, 2007
  • 19. Coenraad MJ, Meinders AE, Taal JC, et al: Hyponatremia in intracranial disorders. Neth J Med 58:123-127, 2001
  • 20. Coenraad MJ, Meinders AE, Vandenbroucke JP, et al: Causes of hyponatremia in the Departments of Internal Medicine and Neurosurgery. Eur J Intern Med 14:302-309, 2003
  • 21. Cort JH: Cerebral salt wasting. Lancet 266:752-754, 1954
  • 22. Cusick JF, Hagen TC, Findling JW: Inappropriate secretion of antidiuretic hormone after transsphenoidal surgery for pituitary tumors. N Engl J Med 311:36-38, 1984
31
"23"
  • 23. Dalan R, Leow MK: Pituitary abscess: our experience with a case and a review of the literature. Pituitary, 2007
  • 24. Damaraju SC, Rajshekhar V, Chandy MJ: Validation study of a central venous pressure-based protocol for the management of neurosurgical patients with hyponatremia and natriuresis. Neurosurgery 40:312-316; discussion 316-317, 1997
  • 25. De Buyst J, Massa G, Christophe C, et al: Clinical, hormonal and imaging findings in 27 children with central diabetes insipidus. Eur J Pediatr 166:43-49, 2007
  • 26. Decaux G: Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by long loop diuretics. Nephron 35:82-88, 1983
  • 27. Decaux G, Brimioulle S, Genette F, et al: Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med 69:99-106, 1980
  • 28. Diringer M, Ladenson PW, Borel C, et al: Sodium and water regulation in a patient with cerebral salt wasting. Arch Neurol 46:928-930, 1989
  • 29. Diringer M, Ladenson PW, Stern BJ, et al: Plasma atrial natriuretic factor and subarachnoid hemorrhage. Stroke 19:1119-1124, 1988
  • 30. Diringer MN, Zazulia AR: Hyponatremia in neurologic patients: consequences and approaches to treatment. Neurologist 12:117-126, 2006
  • 31. Docci D, Cremonini AM, Nasi MT, et al: Hyponatraemia with natriuresis in neurosurgical patients. Nephrol Dial Transplant 15:1707-1708, 2000
  • 32. Elias LL, Antunes-Rodrigues J, Elias PC, et al: Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus. J Clin Endocrinol Metab 82:1243-1247, 1997
  • 33. Ferry RJ, Jr., Kesavulu V, Kelly A, et al: Hyponatremia and polyuria in children with central diabetes insipidus: challenges in diagnosis and management. J Pediatr 138:744-747, 2001
  • 34. Findley T, White HL: The Response of Normal Individuals and Patients with Diabetes Insipidus to the Ingestion of Water. J Clin Invest 16:197-202, 1937
  • 35. Forrest JN, Jr., Cox M, Hong C, et al: Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 298:173-177, 1978
  • 36. Fox JL, Falik JL, Shalhoub RJ: Neurosurgical hyponatremia: the role of inappropriate antidiuresis. J Neurosurg 34:506-514, 1971
  • 37. Fraser CL, Arieff AI: Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med 102:67-77, 1997
  • 38. Fraser JF, Stieg PE: Hyponatremia in the neurosurgical patient: epidemiology, pathophysiology, diagnosis, and management. Neurosurgery 59:222-229; discussion 222-229, 2006
  • 39. Ghirardello S, Hopper N, Albanese A, et al: Diabetes insipidus in craniopharyngioma: postoperative management of water and electrolyte disorders. J Pediatr Endocrinol Metab 19 Suppl 1:413-421, 2006
  • 40. Harrigan MR: Cerebral salt wasting syndrome. Crit Care Clin 17:125-138, 2001
  • 41. Hasan D, Lindsay KW, Wijdicks EF, et al: Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke 20:1156-1161, 1989
  • 42. Hasan D, Wijdicks EF, Vermeulen M: Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol 27:106-108, 1990
  • 43. Helmy A, Vizcaychipi M, Gupta AK: Traumatic brain injury: intensive care management. Br J Anaesth 99:32-42, 2007
  • 44. Hensen J, Henig A, Fahlbusch R, et al: Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol (Oxf) 50:431-439, 1999
  • 45. Hirshberg B, Ben-Yehuda A: The syndrome of inappropriate antidiuretic hormone secretion in the elderly. Am J Med 103:270-273, 1997
32
"46"
  • 46. Hollinshead WH: The Interphase of Diabetes Insipidus. Mayo Clin Proc 39:92-100, 1964
  • 47. Isotani E, Suzuki R, Tomita K, et al: Alterations in plasma concentrations of natriuretic peptides and antidiuretic hormone after subarachnoid hemorrhage. Stroke 25:2198-2203, 1994
  • 48. Jane JA, Jr., Vance ML, Laws ER: Neurogenic diabetes insipidus. Pituitary 9:327-329, 2006
  • 49. Janicic N, Verbalis JG: Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am 32:459-481, vii, 2003
  • 50. Katan M, Morgenthaler NG, Dixit KC, et al: Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay. J Clin Endocrinol Metab 92:2640-2643, 2007
  • 51. Katayama Y, Haraoka J, Hirabayashi H, et al: A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke 38:2373-2375, 2007
  • 52. Kato T, Sawamura Y, Tada M, et al: Occult neurohypophyseal germinomas in patients presenting with central diabetes insipidus. Neurosurg Focus 5:e6, 1998
  • 53. Knox FG, Burnett JC, Jr., Kohan DE, et al: Escape from the sodium-retaining effects of mineralocorticoids. Kidney Int 17:263-276, 1980
  • 54. Kumar S, Berl T: Sodium. Lancet 352:220-228, 1998
  • 55. Kurokawa Y, Uede T, Ishiguro M, et al: Pathogenesis of hyponatremia following subarachnoid hemorrhage due to ruptured cerebral aneurysm. Surg Neurol 46:500-507; discussion 507-508, 1996
  • 56. Laredo S, Yuen K, Sonnenberg B, et al: Coexistence of central diabetes insipidus and salt wasting: the difficulties in diagnosis, changes in natremia, and treatment. J Am Soc Nephrol 7:2527-2532, 1996
  • 57. Laureno R, Karp BI: Myelinolysis after correction of hyponatremia. Ann Intern Med 126:57-62, 1997
  • 58. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 339:321-328, 1998
  • 59. Lindholm J: Diabetes insipidus: historical aspects. Pituitary 7:33-38, 2004
  • 60. Lipsett MB, Maclean JP, West CD, et al: An analysis of the polyuria induced by hypophysectomy in man. J Clin Endocrinol Metab 16:183-195, 1956
  • 61. Loh JA, Verbalis JG: Diabetes insipidus as a complication after pituitary surgery. Nat Clin Pract Endocrinol Metab 3:489-494, 2007
  • 62. Maclean JP, Lipsett MB, Li MC, et al: Regulation of salt metabolism after hypophysectomy in man. J Clin Endocrinol Metab 17:346-355, 1957
  • 63. Maesaka JK, Gupta S, Fishbane S: Cerebral salt-wasting syndrome: does it exist? Nephron 82:100-109, 1999
  • 64. Maghnie M, Ghirardello S, De Bellis A, et al: Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity. Clin Endocrinol (Oxf) 65:470-478, 2006
  • 65. Mori T, Katayama Y, Kawamata T, et al: Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 91:947-952, 1999
  • 66. Munger MA: New agents for managing hyponatremia in hospitalized patients. Am J Health Syst Pharm 64:253-265, 2007
  • 67. Musch W, Thimpont J, Vandervelde D, et al: Combined fractional excretion of sodium and urea better predicts response to saline in hyponatremia than do usual clinical and biochemical parameters. Am J Med 99:348-355, 1995
  • 68. Nathan BR: Cerebral correlates of hyponatremia. Neurocrit Care 6:72-78, 2007
  • 69. Naval NS, Stevens RD, Mirski MA, et al: Controversies in the management of aneurysmal subarachnoid hemorrhage. Crit Care Med 34:511-524, 2006
  • 70. Nelson PB, Seif SM, Maroon JC, et al: Hyponatremia in intracranial disease: perhaps not the syndrome of inappropriate secretion of antidiuretic hormone
33
"(SIADH). J Neurosurg..."
  • (SIADH). J Neurosurg 55:938-941, 1981
  • 71. Nemergut EC, Zuo Z, Jane JA, Jr., et al: Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients. J Neurosurg 103:448-454, 2005
  • 72. Nomikos P, Ladar C, Fahlbusch R, et al: Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas -- a study on 721 patients. Acta Neurochir (Wien) 146:27-35, 2004
  • 73. Ogden AT, Mayer SA, Connolly ES, Jr.: Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery 57:207-215; discussion 207-215, 2005
  • 74. Olson BR, Gumowski J, Rubino D, et al: Pathophysiology of hyponatremia after transsphenoidal pituitary surgery
  • Isolated hyponatremia after transsphenoidal pituitary surgery. J Neurosurg 87:499-507, 1997
  • 75. Olson BR, Rubino D, Gumowski J, et al: Isolated hyponatremia after transsphenoidal pituitary surgery. J Clin Endocrinol Metab 80:85-91, 1995
  • 76. Olson DR, Buchan GC, Porter GA: The syndrome of inappropriate antidiuretic hormone secretion; an unusual case. Arch Intern Med 124:741-747, 1969
  • 77. Palmer BF: Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab 14:182-187, 2003
  • 78. Perkins RM, Yuan CM, Welch PG: Dipsogenic diabetes insipidus: report of a novel treatment strategy and literature review. Clin Exp Nephrol 10:63-67, 2006
  • 79. Peters JP, Welt LG, Sims EA, et al: A salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians 63:57-64, 1950
  • 80. Qureshi AI, Suri MF, Sung GY, et al: Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 50:749-755; discussion 755-746, 2002
  • 81. Rabinstein AA, Wijdicks EF: Hyponatremia in critically ill neurological patients. Neurologist 9:290-300, 2003
  • 82. Reeder RF, Harbaugh RE: Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients. J Neurosurg 70:201-206, 1989
  • 83. Renneboog B, Musch W, Vandemergel X, et al: Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 119:71 e71-78, 2006
  • 84. Riggs JE: Neurologic manifestations of electrolyte disturbances. Neurol Clin 20:227-239, vii, 2002
  • 85. Robertson GL: Thirst and vasopressin function in normal and disordered states of water balance. J Lab Clin Med 101:351-371, 1983
  • 86. Robertson GL, Aycinena P, Zerbe RL: Neurogenic disorders of osmoregulation. Am J Med 72:339-353, 1982
  • 87. Saeki N, Tokunaga H, Wagai N, et al: MRI of ectopic posterior pituitary bright spot with large adenomas: appearances and relationship to transient postoperative diabetes insipidus. Neuroradiology 45:713-716, 2003
34
"88"
  • 88. Sata A, Hizuka N, Kawamata T, et al: Hyponatremia after transsphenoidal surgery for hypothalamo-pituitary tumors. Neuroendocrinology 83:117-122, 2006
  • 89. Schwartz WB, Bennett W, Curelop S, et al: A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. 1957. J Am Soc Nephrol 12:2860-2870, 2001
  • 90. Seckl JR, Dunger DB, Bevan JS, et al: Vasopressin antagonist in early postoperative diabetes insipidus. Lancet 335:1353-1356, 1990
  • 91. Sheehan JM, Sheehan JP, Douds GL, et al: DDAVP use in patients undergoing transsphenoidal surgery for pituitary adenomas. Acta Neurochir (Wien) 148:287-291; discussion 291, 2006
  • 92. Sherlock M, O'Sullivan E, Agha A, et al: The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol (Oxf) 64:250-254, 2006
  • 93. Shimoda M, Yamada S, Yamamoto I, et al: Atrial natriuretic polypeptide in patients with subarachnoid haemorrhage due to aneurysmal rupture. Correlation to hyponatremia. Acta Neurochir (Wien) 97:53-61, 1989
  • 94. Singer PA, Sevilla LJ: Postoperative endocrine management of pituitary tumors. Neurosurg Clin N Am 14:123-138, 2003
  • 95. Sivakumar V, Rajshekhar V, Chandy MJ: Management of neurosurgical patients with hyponatremia and natriuresis. Neurosurgery 34:269-274; discussion 274, 1994
  • 96. Smith D, McKenna K, Moore K, et al: Baroregulation of vasopressin release in adipsic diabetes insipidus. J Clin Endocrinol Metab 87:4564-4568, 2002
  • 97. Smith D, Moore K, Tormey W, et al: Downward resetting of the osmotic threshold for thirst in patients with SIADH. Am J Physiol Endocrinol Metab 287:E1019-1023, 2004
  • 98. Steele A, Gowrishankar M, Abrahamson S, et al: Postoperative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination. Ann Intern Med 126:20-25, 1997
  • 99. Strom TM, Hortnagel K, Hofmann S, et al: Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 7:2021-2028, 1998
  • 100. Takaku A, Shindo K, Tanaka S, et al: Fluid and electrolyte disturbances in patients with intracranial aneurysms. Surg Neurol 11:349-356, 1979
  • 101. Taplin CE, Cowell CT, Silink M, et al: Fludrocortisone therapy in cerebral salt wasting. Pediatrics 118:e1904-1908, 2006
  • 102. Taylor SL, Tyrrell JB, Wilson CB: Delayed onset of hyponatremia after transsphenoidal surgery for pituitary adenomas. Neurosurgery 37:649-653; discussion 653-644, 1995
  • 103. Tierney WM, Martin DK, Greenlee MC, et al: The prognosis of hyponatremia at hospital admission. J Gen Intern Med 1:380-385, 1986
  • 104. Tisdall M, Crocker M, Watkiss J, et al: Disturbances of sodium in critically ill adult neurologic patients: a clinical review. J Neurosurg Anesthesiol 18:57-63, 2006
  • 105. Tomida M, Muraki M, Uemura K, et al: Plasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage. Stroke 29:1584-1587, 1998
  • 106. Tymms J, Clark JD, Griffith HB, et al: Pituitary surgery and inappropriate antidiuretic hormone secretion. J R Soc Med 85:302, 1992
35
"107"
  • 107. Verbalis JG: Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab 17:471-503, 2003
  • 108. Vingerhoets F, de Tribolet N: Hyponatremia hypo-osmolarity in neurosurgical patients. "Appropriate secretion of ADH" and "cerebral salt wasting syndrome". Acta Neurochir (Wien) 91:50-54, 1988
  • 109. Vokes TJ, Gaskill MB, Robertson GL: Antibodies to vasopressin in patients with diabetes insipidus. Implications for diagnosis and therapy. Ann Intern Med 108:190-195, 1988
  • 110. Walker V: Fluid balance disturbances in neurosurgical patients: physiological basis and definitions. Acta Neurochir Suppl (Wien) 47:95-101, 1990
  • 111. Weinand ME, O'Boynick PL, Goetz KL: A study of serum antidiuretic hormone and atrial natriuretic peptide levels in a series of patients with intracranial disease and hyponatremia. Neurosurgery 25:781-785, 1989
  • 112. Weiss-Guillet EM, Takala J, Jakob SM: Diagnosis and management of electrolyte emergencies. Best Pract Res Clin Endocrinol Metab 17:623-651, 2003
  • 113. Wijdicks EF, Heublein DM, Burnett JC, Jr.: Increase and uncoupling of adrenomedullin from the natriuretic peptide system in aneurysmal subarachnoid hemorrhage. J Neurosurg 94:252-256, 2001
  • 114. Wijdicks EF, Ropper AH, Hunnicutt EJ, et al: Atrial natriuretic factor and salt wasting after aneurysmal subarachnoid hemorrhage. Stroke 22:1519-1524, 1991
  • 115. Wijdicks EF, Vermeulen M, Hijdra A, et al: Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann Neurol 17:137-140, 1985
  • 116. Wijdicks EF, Vermeulen M, van Brummelen P, et al: Digoxin-like immunoreactive substance in patients with aneurysmal subarachnoid haemorrhage. Br Med J (Clin Res Ed) 294:729-732, 1987
  • 117. Wijdicks EF, Vermeulen M, van Brummelen P, et al: The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 90:209-214, 1988
  • 118. Wise-Faberowski L, Soriano SG, Ferrari L, et al: Perioperative management of diabetes insipidus in children [corrected]. J Neurosurg Anesthesiol 16:14-19, 2004
  • 119. Wong MF, Chin NM, Lew TW: Diabetes insipidus in neurosurgical patients. Ann Acad Med Singapore 27:340-343, 1998
  • 120. Zada G, Liu CY, Fishback D, et al: Recognition and management of delayed hyponatremia following transsphenoidal pituitary surgery. J Neurosurg 106:66-71, 2007
  • 121. Zerbe R, Stropes L, Robertson G: Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 31:315-327, 1980







36